Your browser doesn't support javascript.
loading
Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.
Lamy, Andre; Eikelboom, John; Sheth, Tej; Connolly, Stuart; Bosch, Jackie; Fox, Keith A A; Zhu, Jun; Lonn, Eva; Dagenais, Gilles; Widimsky, Petr; Branch, Kelly R H; Bhatt, Deepak L; Zheng, Zhe; Straka, Zbynek; Dagenais, Francois; Kong, Ye; Marsden, Tamara; Lee, Shun Fu; Copland, Ingrid; Yusuf, Salim.
Afiliação
  • Lamy A; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; CADENCE Research Group, Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMas
  • Eikelboom J; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Sheth T; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Connolly S; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Bosch J; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Zhu J; FuWai Hospital, Beijing, China.
  • Lonn E; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Dagenais G; Institut Universitaire de Cardiologie et de Pnemologie de Québec, Quebec City, Quebec, Canada.
  • Widimsky P; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Branch KRH; University of Washington Medical Center, Seattle, Washington.
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.
  • Zheng Z; FuWai Hospital, Beijing, China.
  • Straka Z; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Dagenais F; Quebec Heart and Lung University Institute, Laval University, Quebec City, Quebec, Canada.
  • Kong Y; Shanghai Chest Hospital Affiliated with Shanghai Jiao Tong University, Shanghai, China.
  • Marsden T; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Lee SF; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Copland I; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Yusuf S; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
J Am Coll Cardiol ; 73(2): 121-130, 2019 01 22.
Article em En | MEDLINE | ID: mdl-30654882

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Aspirina / Ponte de Artéria Coronária / Fibrinolíticos / Inibidores do Fator Xa / Rivaroxabana / Oclusão de Enxerto Vascular Tipo de estudo: Clinical_trials Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Aspirina / Ponte de Artéria Coronária / Fibrinolíticos / Inibidores do Fator Xa / Rivaroxabana / Oclusão de Enxerto Vascular Tipo de estudo: Clinical_trials Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2019 Tipo de documento: Article